Testing effectiveness (Phase 2)Study completedNCT03844945
What this trial is testing
Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
Who this might be right for
Open Angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 215